• FirefoxUpgrade to the new Firefox »
  •  Dow Up0.15% Nasdaq Up0.36%

    More On BLRX

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    Financials


    BioLineRx, Ltd. (BLRX)

    -NasdaqCM
    1.72 0.03(1.78%) Dec 19, 4:00PM EST
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
    Total Revenue -   -   -  
    Cost of Revenue -   -   -  
    Gross Profit -   -   -  
    Operating Expenses
    Research Development12,693  17,235  11,147  
    Selling General and Administrative4,992  4,624  4,192  
    Non Recurring -   -   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (17,685) (21,859) (15,339)
    Income from Continuing Operations
    Total Other Income/Expenses Net1,956  3,425  3,329  
    Earnings Before Interest And Taxes(15,728)(18,435)(12,010)
    Interest Expense1,972  2,007  1,115  
    Income Before Tax(17,700)(20,442)(13,125)
    Income Tax Expense -   -   -  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(17,700)(20,442)(13,125)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (17,700) (20,442) (13,125)
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (17,700) (20,442) (13,125)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.